Manage episode 257035978 series 2422086
The COVID-19 pandemic is impacting every corner of our world, and neuropsychology is certainly not immune from its effects. In particular, many neuropsychological clinics have temporarily shut down operations in response to the widespread call for social distancing. With this as the backdrop, we speak with Munro Cullum, Ph.D., ABPP-CN, about teleneuropsychology and telemedicine in general. We distinguish between pre-COVID-19 teleneuropsychological evaluations, conducted in clinics and other controlled environments, and the current push for home-to-home teleneuropsychology. We then dive into the details of teleneuropsychology, including topics such as research evidence for feasibility, reliability, and validity of this methodology, patient acceptability, environmental challenges, patient privacy and informed consent, and trainee clinical hours, among others. Throughout the interview, Dr. Cullum summarizes the current literature and provides advice, tips, and guidance for interested researchers and clinicians.
Show notes are available at www.NavNeuro.com/41
If you’d like to support the show, here are a few easy ways:
1) Tell your friends and colleagues about it
2) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes
3) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro)
Thanks for listening, and join us next time as we continue to navigate the brain and behavior!
[Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]